Opiate receptors have been solubilized from toad brain membranes in active form by using digitonin. Between 40% and 50% ofthe stereospecific binding activity present in toad brain membranes is recoverable in the ultracentrifugal supernatant of digitonin extracts. Binding of opiates to the solubilized receptor is enhanced 4-to 5-fold by decreasing digitonin concentration to 0.1% or less prior to binding. The solubilized receptor is similar to the membrane-bound receptor in its affinity for various ligands and its sensitivity to heat, trypsin, and N-ethylmaleimide. Moreover, the sodium effect seen in membrane-bound receptor is retained in the solubilized preparation. Both membrane-bound and soluble toad receptors show weak binding of enkephalins, suggesting that they are predominantly of the 1A type. The solubilized opiate receptor has an approximate molecular weight of 350,000-400,000. Purification of up to 20-fold has been achieved by gel filtration on Sepharose CL-6B.
The initial step leading to many of the pharmacological actions of opiates involves their binding to stereospecific membranebound receptors. Efforts, in the past, to solubilize these receptors in a condition in which stereospecific binding of opiates is maintained in solution have been unsuccessful. A major impediment has been the inactivation of opiate receptors by extremely low concentrations of detergents commonly used to solubilize membrane proteins. Nevertheless, we have been able to solubilize an etorphine-receptor complex by using the nonionic detergent BRIJ-36T (1) . However, the dissociation rate ofetorphine from this solubilized complex was greater than that from membrane-bound receptor and, more significantly, stereospecific binding of opiates to unbound or dissociated solubilized macromolecular material could not be demonstrated.
We have published a preliminary report on the successful solubilization of active opiate receptors from the brain of the toad, Bufo nmrinus (2) . The solubilization of these receptors with digitonin was suggested by previous work with ,B-adrenergic receptors. Success in the solubilization of ,B-adrenergic receptors in active form with digitonin was attained from nonmammalian sources (3, 4) but not from mammalian sources (5, 6) .
In the present communication, we report on the characterization and partial purification ofthe solubilized opiate receptor from toad brain. The solubilized moiety has been characterized here only with respect to its ability to bind opiates stereospecifically and not with respect to the presence of other elements of the receptor complex (transducing component, etc.). Nevertheless, in line with common practice, the term receptor is used.
MATERIALS AND METHODS
[3H]Diprenorphine (specific activity, 18.6 Ci/mmol; 1 Ci = 3.7 x lo10 becquerels), [3H] Membranes from adult toad (B. marinus) brain were prepared essentially as described for the rat (7) . Toads ofboth sexes were sacrificed by decapitation, and the palate was removed to allow excision of the brain. Homogenization of brains was carried out in 50 mM Tris-HCl, pH 7.4/1 mM dipotassium EDTA (buffer A) with a Polytron (Brinkman) at a setting of6 for 20 sec. Dipotassium EDTA is added to the buffer because it seemed to enhance stability of frozen homogenates and frozen solubilized preparations. Binding in fresh membrane or solubilized preparations was unaffected by the presence or absence of EDTA. Homogenates were centrifuged at 20,000 X g for 20 min, and the pellets were resuspended (1:6, wet weight ofbrain per vol) in 0.32 M sucrose/ 1 mM dipotassium EDTA and stored at -700C until use.
In membrane-binding experiments, homogenates were suspended in buffer A at a protein concentration of 0.7-1.2 mg/ ml. Membranes were incubated for 15 min at 370C with tritiated ligand in the presence of1 pLM dextrorphan or levorphanol. For consistency of results, all binding samples in this report were cooled in an ice-water bath for 15 min prior to filtration through Whatman GF/B or GF/C filters. Radioactivity remaining on dried filters was determined by scintillation spectroscopy. Protein was determined by the Lowry method (8) .
Solubilization of membranes with digitonin in buffer A was carried out at 0°C for 30 min at a protein concentration of 0.7-1.0 mg/ml. After centrifugation at 100,000 x g for 60 min, aliquots of undiluted or diluted clear supernatant were incubated with tritiated ligand in the presence and absence of 1 ,uM naloxone. Bound tritiated ligands were separated from free ligands on columns (0.8 x 20 cm) of Sephadex G-50 (fine) in buffer A at 4-6°C. Radioactivity in successive 1-ml eluate fractions was determined. In previous results reported for membrane-bound receptors by Simon and Groth (11) . These findings support the participation of protein in opiate binding to the solubilized receptors. Virtually all ofthe original binding activity (94%) was left after storage ofsolubilized material at -70TC for 90 days (Fig. 4) . This finding makes possible the processing of large amounts of material for further investigation and purification.
The characteristic effect ofsodium ions on membrane-bound opiate receptors has been well established (12, 13) . Sodium ions effectively increase the binding of opiate antagonists and decrease the binding of opiate agonists. This sodium effect is retained by the solubilized opiate-binding material. When radioreceptor assays were performed in the presence of 100 mM NaCl, binding of the potent antagonist, diprenorphine, was increased by 80-90% and that ofthe potent agonist etorphine was reduced by 40-50%.
The molecular weight of the solubilized receptor was determined by chromatography on Sepharose CL-6B columns (2 X 108 cm) calibrated with proteins of known molecular weight. Aliquots (5 ml) of ultracentrifugal supernatant of a digitonin extract of toad brain membranes were prebound with [3H]etorphine in the presence and absence of a 1000-fold excess of unlabeled etorphine and applied separately to two Sepharose columns. The chromatographic-profiles of those samples bound in the absence of unlabeled etorphine showed a radioactive peak that was eluted at a volume consistent with an estimated molecular weight of about 350,000-400,000. Radioactivity from samples bound in the presence of excess unlabeled etorphine Gel chromatography has in a single step yielded a purification of 10-to 20-fold. This partially purified material has an approximate molecular weight of350,000-400,000, in close agreement with that ofthe etorphine-macromolecular receptor complex solubilized with BRIJ-36T from rat brain. A similar molecular weight was obtained by Zukin and Kream (14) for a BRIJ 36T-solubilized enkephalin-macromolecular receptor complex.
We recently have had some success in solubilizing opiate receptors from rat brain, using the detergent deoxycholate (unpublished results). Using a new type of detergent, which is a zwitterionic derivative of cholic acid, Simonds et al (15) have solubilized active opiate receptors from neuroblastoma-glioma hybrid cell (NG 10815) membranes and rat brain membranes. Bidlack and Abood (16, 17) have reported the solubilization of opiate-binding sites from rat brain, using Triton X-100. The solubilization of specific opiate-binding sites with properties similar to those of membrane-bound receptors provides the basis for their further biochemical characterization and purification. As more information is accumulated concerning the nature of other components of the opiate-receptor complex (coupling factors, enzymes, etc.), their presence in the solubilized preparation and their state of coupling to the binding site will be examined.
